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Abstract
Background: Regional trade agreements are major international policy instruments that shape macro-economic
and political systems. There is widespread debate as to whether and how these agreements pose risks to public
health. Here we perform a comprehensive systematic review of quantitative studies of the health impact of trade
and investment agreements. We identified studies from searches in PubMed, Web of Science, EMBASE, and Global
Health Online. Research articles were eligible for inclusion if they were quantitative studies of the health impacts of
trade and investment agreements or policy. We systematically reviewed study findings, evaluated quality using the
Quality Assessment Tool from the Effective Public Health Practice Project, and performed network citation analysis
to study disciplinary siloes.
Results: Seventeen quantitative studies met our inclusion criteria. There was consistent evidence that implementing
trade agreements was associated with increased consumption of processed foods and sugar-sweetened beverages.
Granting import licenses for patented drugs was associated with increased access to pharmaceuticals. Implementing
trade agreements and associated policies was also correlated with higher cardiovascular disease incidence and higher
Body Mass Index (BMI), whilst correlations with tobacco consumption, under-five mortality, maternal mortality, and life
expectancy were inconclusive. Overall, the quality of studies is weak or moderately weak, and co-citation analysis
revealed a relative isolation of public health from economics.
Conclusion: We identified limitations in existing studies which preclude definitive conclusions of the health impacts of
regional trade and investment agreements. Few address unobserved confounding, and many possible consequences
and mechanisms linking trade and investment agreements to health remain poorly understood. Results from our
co-citation analysis suggest scope for greater interdisciplinary collaboration. Notwithstanding these limitations,
our results find evidence that trade agreements pose some significant health risks. Health protections in trade
and investment treaties may mitigate these impacts.
Keywords: Trade and investment agreements (RTAs), Trade policy, Foreign investment policy, Diets, Tobacco,
Non-communicable diseases, Health outcomes, Systematic review, Co-citation analysis
Background
Regional trade and investment agreements (RTAs) are
increasingly being used to promote international integra-
tion and economic growth. This has taken particular
prominence as world trade has slowed in the wake of
the 2008 global financial crisis: in 1990 there were 22 bi-
lateral and regional RTAs, which rose to over 270 by
2016, as shown in Fig. 1 [1, 2]. Two large RTAs have
been at the centre of recent negotiations: the Trans-
Pacific Partnership, between the US and 11 Pacific Rim
countries, signed in February 2016; and the Transatlantic
Trade and Investment Partnership, between the US and
the European Union (EU), signed in October 2016 [3].
These RTAs are as much about facilitating trade as redu-
cing barriers to investment, such as by creating investor
protections and by enabling private companies to par-
ticipate in public sector procurement [4].
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There has long been debate about the overall impact
of RTAs on populations, not just economically, but also
in terms of health and well-being [5–7]. In 2015, dis-
putes about health in the World Trade Organization’s
(WTO) Technical Barriers to Trade Committee reached
record numbers. The WTO notes that protecting health
is a dominant trade concern among members who seek
to “strike a balance between trade and health” as they
face potential economic costs and legal challenges when
introducing new health measures [8, 9].
Concerned public health advocates argue that RTAs
pose health risks through a number of mechanisms. One
is that they could worsen dietary quality through enhan-
cing transnational trade in unhealthy foods enriched
with salt, sugar and fat [10–12]. Another is that RTAs
could facilitate the spread of tobacco and alcohol use
by weakening public health programmes, as well as
increase the prices of pharmaceuticals by extending
patent protections [13, 14]. In contrast, advocates of
RTAs point to several benefits that achieve progress to-
wards the Sustainable Development Goals [15]. This
includes increasing the security of food supply systems
and reducing malnutrition, as well as improved access
to pharmaceuticals, either through importation or foreign
investment [16–18].
Previous studies of RTAs have been published in dispar-
ate disciplines and have analysed extensively the impact of
RTAs on a range of political and economic phenomena
[4]. Studies of the health impacts of RTAs, together with
their broader social consequences, are conspicuous by
their absence from this empirical literature. A number of
possible mechanisms linking RTAs to health are shown
in the conceptual framework in Fig. 2, which incorpo-
rates findings from different disciplines, including so-
cial epidemiology, public health, political economy and
economics. The conceptual framework treats RTAs as a
distal upstream determinant of population health and
health equity via their impact on social and environ-
mental factors that influence downstream proximal de-
terminants of health outcomes [19–21]. The framework
focuses on three main intermediate mechanisms linking
RTAs to health outcomes: production, consumption,
and health-services and policy. This builds on previous
identification by Labonte and Schrecker (2007), Blouin
et al. (2009), and Friel et al. (2015) [13, 22, 23].
First, RTAs can impact consumption via increased im-
portation of food, soft-drinks and alcoholic beverages,
and tobacco products. This increased competition from
international imports can also lead domestic firms to
lower prices, so further increasing consumption. Second,
RTAs can alter the scope and scale of production through
trade, Foreign Direct Investment (FDI) and subsequent
competition with domestic firms. This can impact in-
comes, including levels and degree of inequality, employ-
ment, job security, and working conditions, and may have
additional consequences for the environment via pollution
and climate change. Changes to production also affect
consumption of food, beverages and tobacco products via
increased foreign investment in domestic production
and intensified local competition, or via changing incomes
and demand.
Third, RTAs have specific clauses which may impact
health-services and policy. These can, for example, es-
tablish public procurement rules, investor protections
and dispute settlement procedures that impact the abil-
ity or willingness of governments to introduce new regu-
lations or policies that protect health, such as food and
tobacco labelling (so-called ‘regulatory chill’). The nature
of such regulations or, indeed, their absence, can, in turn,
also impact the scope and scale of production and con-
sumption. As a result, RTAs can have a substantial effect
on health and access to care via changes to the availability
of medicines, social protection, and health-service cover-
age: ‘protective factors’ that determine the extent to which
risk-factor exposure ultimately impacts peoples’ health.
RTAs may therefore impact population health and
health equity, for better or for worse, via myriad and
complex pathways. Yet, a comprehensive understanding
of these mechanisms and consequences is currently lim-
ited as previous systematic reviews did not scrutinise
major pathways to impact. These include, among others,
alcohol, tobacco, public health policymaking, and social
protection programmes. Instead, previous reviews were
relatively narrow in scope, with one previous review of
the effects of trade and FDI on health systems, a second
on non-nutritive health outcomes, and a third on the ef-
fects of RTAs on food environments [24–26]. Other ana-
lyses of RTAs and health are summaries, theoretical
overviews, and policy commentaries, with contradictory
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claims [7, 12, 14, 27, 28]. The quality of research also
varies considerably, as research designs span case study
approaches to rigorous quasi-experimental methodolo-
gies, but most previous reviews and commentaries did
not evaluate study quality [29, 30]. Here we address
these gaps in the literature by reviewing high-quality,
quantitative studies of the impact of RTAs on a wide
range of health outcomes and corresponding pathways.
Methods
Selection criteria
Figure 3 shows the PRISMA diagram depicting our
study identification, screening and exclusion procedures.
First, we searched Web of Science, Scopus, PubMed,
EMBASE, and Global Health Online on 19 January 2016
for articles published since 1960. Following the method-
ology of Friel and colleagues (2013) we used terms that
captured studies of trade and investment policies that
were not analysed in the context of a specific RTA but
are common components of many RTAs. Additional
file 1: describes our search operators in detail. This
search identified 7,802 papers. To ensure completeness
we reviewed the bibliographies of commentaries and
book chapters and searched the websites of relevant
international organisations including the World Health
Organisation and WTO, identifying an additional 6 studies.
Out of 7,808 identified studies we excluded duplicates
(n = 1,410 studies), non-English studies (n = 90 studies),
those which were not full articles (n = 4 studies), ana-
lyses which did not study the health effects RTAs or
trade policies (n = 6,174 studies), and qualitative case
studies (n = 113 studies). To review study findings we
then extracted details of the study’s title, author, coun-
tries, years, research question, study design, measure-
ment, method of analysis, and main findings. We then
categorised study findings according to the macro-social
framework, grouping studies into three categories: i)
food, beverage and tobacco consumption, ii) access to
medicines, and iii) overall health outcomes. We conducted
our systematic review according to the PRISMA guide-
lines set out in Moher et al. (2009) (see Additional file 1:
for full PRISMA checklist).
Fig. 2 Macro-social model outlining potential health effects of RTAs and associated mechanisms. Notes: Numbers 1–3 identify whether outcomes
and pathways are linked indirectly via changes to (1) trade flows, (2) foreign direct investment flows (FDI), or (3) directly via RTA clauses. Relevant
RTA provisions were identified from Dur and Baccini (2014)
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Quality assessment
To rate methodological quality and evaluate risk of bias we
used an updated version of the Quality Assessment Tool
from the Effective Public Health Practice Project [31]. This
scores studies between 1 and 3 in six components, measur-
ing the strength of: (1) study design, (2) selection bias, (3)
confounders, (4) data collection, (5) data analysis, and (6)
reporting (see Additional file 1) [32].
Network co-citation analysis
Since the prospective links between RTAs and health inte-
grate findings from disparate disciplines we analyse co-
citation patterns to identify cross-disciplinary fertilisation
of included studies. Co-citation measures the frequency
with which two documents are cited together by other doc-
uments. We analyse co-citation patterns to assess whether
insights from different fields are being acknowledged with
one another or are instead located in disciplinary siloes. As
has been noted elsewhere, this is important as a failure to
include work from other disciplines could lead to partial or
incorrect conclusions [33–35]. To map co-citation patterns
we extracted citation data from PubMed and Web of
Science and analysed citation patterns using network-
clustering algorithms in VOSviewer 1.6.1 [36].
Funder involvement
The funder of the study had no role in study design, data
collection, data analysis, data interpretation, or writing
of the report. The corresponding author had full access
to all the data in the study and had final responsibility
for the decision to submit for publication.
Results
Study characteristics
Searches and exclusion identified 17 quantitative re-
search articles which are summarised in Table 1. Eleven
studies analysed the impact of RTAs on changes in the
availability and consumption of food, tobacco and bever-
ages. One study analysed the associations between RTAs
and access to pharmaceuticals. Six studies analysed asso-
ciations of RTAs and trade policies with health outcomes
including rates of under-five and maternal mortality, life
expectancy, Body Mass Index (BMI), and cardiovascular
disease incidence.
i) Impact of RTAs on consumption: food, beverages and
tobacco
Among the eleven studies in this category, six were
bivariate analyses, four were multivariate analyses, and
one used a natural experiment design. Overall, entering
into trade agreements and implementing associated pol-
icies were correlated with increases in imports and con-
sumption of edible oils, meats, processed foods, and
sugar-sweetened beverages. Studies of tobacco consump-
tion reported contrasting results.
Fig. 3 PRISMA diagram showing study identification, screening, and inclusion. Notes: flow diagram based on PRISMA guidelines set out in
Moher et al. 2009
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Food
The five bivariate analyses identified increased imports,
supply, sales and consumption of processed foods, edible
oils and meats after reducing tariffs on these products.
For example, Chatterjee et al. identify an 111% increase
in edible oil imports, a decrease in consumption of
cereal items, and a 12.5% rise in processed food con-
sumption in urban areas after tariffs were reduced in
India after liberalisation reforms in the 1990s [37]. A fur-
ther four studies identified increases in the supply of
animal products, processed foods and staple grains after
tariffs fell in Central America, Latin America, Africa, the
Pacific, and Southeast Asia [12, 30, 38].
Two multivariate studies analysed the associations be-
tween trade agreements and the demand for staple
grains and processed foods. Schram et al. use structural
equation modelling to analyse the association between
the KOF (Konjunkturforschungsstelle Swiss Economic
Institute) economic globalisation index and per capita
sales of multiple food products in 48 Sub-Saharan African
countries 1995–2012. The authors’ identify an increase
in foreign investment inflows, imports of high-sugar
and energy-dense foods, grocery retail sales, and daily
caloric intake in all countries [39]. Sharif et al. (2008)
analyse the effect of the 1994 Uruguay round of trade
liberalisation agreements on changes to the production
and consumption of wheat and rice in Pakistan, 1993–
2005, and identify a rise in the wholesale price of rice
and wheat production and a corresponding reduction
in demand [40].
Beverages
One multivariate study by Stuckler et al. analysed the as-
sociation between entering into RTAs with the United
States and soft-drinks consumption in 50 low- and
middle-income countries. They identify 63.4% higher
levels of soft-drink consumption per capita in countries
with US RTAs [41]. One study analysed the effects of
RTAs on beverage consumption using quasi-experimental
methods. Schram et al. (2015) analysed a natural experi-
ment in Vietnam and the Philippines to evaluate the effect
of joining the WTO upon the sales of sugar-sweetened
beverages. The authors find that after Vietnam removed
trade restrictions to join the WTO, the growth rate of
soft-drink sales per capita rose 4.6 L per annum faster in
Vietnam compared with the Philippines [29].
Table 1 Studies of RTAs and health meeting inclusion criteria
Source Countries studied Years
studied
Analysis Category
Bozorgmehr and San Sebastian
2014 [47]
22 high TB-burden countries 1990–2010 Multivariate Health outcomes (TB and
HIV incidence)
Chaloupka and Laixuthai 1996 [43] 10 Asian countries 1970–1991 Multivariate Cigarettes
Chatterjee et al., 2011 [37] India 1990–2006 Bivariate Food
Vogli RD et al. 2014 [49] 127 low-, middle- and high-income
countries
1980–2008 Multivariate BMI
Drope and Chavez, 2014 [42] 9 Southeast Asian countries 1999–2012 Bivariate Cigarettes
Goryakin et al., 2015 [48] 56 low- and middle-income countries 1991–2009 Multivariate BMI
Hawkes 2007 Central America (Honduras, El Salvador,
Nicarague, Costa Rica, Guatemala), India,
South Africa, Bangladesh, Uganda
various Bivariate Food
Hawkes 2010 [12] Brazil, Argentina, Indonesia, Malaysia,
China and India
1990–2005 Bivariate Food
Schram et al. 2013 [39] 48 Sub-Saharan African countries 1995–2012 Bivariate Food and beverages
Schram et al. 2015 [29] Vietnam and The Philippines 1999–2013 Natural
experiment
Beverages
Sharif et al. 2008 [40] Pakistan 1993–2005 Multivariate Health outcomes (mortality)
Stuckler et al. 2012 [41] 80 low- and middle- income countries 1997–2010 Multivariate Food and beverages
Tausch 2015 [46] 99 low-, middle- and high-income countries 1970–2005 Multivariate Health outcomes (mortality)
Thow and Hawkes 2009 [30] Honduras, Costa Rica, Guatemala, El Salvador,
Nicaragua
1990–2006 Bivariate Food
Thow and Snowdon 2010 [39] 10 Pacific Island countries 1961–2005 Bivariate Food
Umana-Pena et al. 2014 [45] WTO member countries 1995–2010 Multivariate Health outcomes (mortality)
Yamabhai et al. 2011 [41] Thailand 2006–2013 Bivariate Medicines and medical
technologies
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Tobacco
One bivariate study by Drope et al. analysed the association
between changes to cigarette tariffs and cigarette consump-
tion per capita in Southeast Asia in 1999 and 2012 and
reported no universal association [42]. A multivariate ana-
lysis by Chaloupka et al. estimated cross-national longitu-
dinal fixed-effects models to study the association between
legal disputes with the US tobacco industry and cigarette
consumption in 10 Asian countries, 1970–1992. The au-
thors estimate that removing tobacco industry protections
in accordance with the resolution agreement increased per
capita cigarette consumption by nearly 10% by 1991 [43].
ii) Impact of RTAs on access to medicines and
technologies
We identified one study which analysed associations be-
tween trade policy and access to pharmaceuticals. Yambhai
et al. (2011) analysed the effects of granting import licenses
for seven generic equivalents of domestically patented
drugs in Thailand, 2002–2008. By calculating differences
between extrapolated pre-intervention and observed post-
intervention access rates the authors estimated that an
additional 84,158 patients received access to the drugs and
12,493 QALYs were gained due to the reforms [44].
iii) Impact of RTAs on overall health outcomes
Six studies analysed the effects of RTAs and trade pol-
icies on health outcomes, including rates of under-five
and maternal mortality, life expectancy, tuberculosis
incidence, Body Mass Index (BMI), and cardiovascular
disease incidence. All six studies used multivariate statis-
tical methods. Overall, implementing liberalisation pol-
icies and trade agreements was linked with higher BMIs
and cardiovascular disease incidence, but there was no
consistent association with under-five and maternal
mortality, life expectancy and tuberculosis incidence.
Turning first to mortality and life expectancy, Umana-
Pena et al. (2015) asked whether there was an associ-
ation with liberalisation in the service sector in WTO
member countries, 1994–2010. In cross-sectional regres-
sion models higher levels of service sector liberalisation
were associated with lower maternal and infant mortality
and longer life-expectancy, but greater progress in liber-
alisation between 1995 and 2010 was not associated with
changes in under-5 mortality, maternal mortality, or life
expectancy [45]. In contrast, Tausch et al. studied the as-
sociation between the economic globalisation compo-
nent of the KOF index and infant mortality in 99 low-,
middle- and high-income countries, 1970–2005, finding
that greater restrictions on FDI and trade were associ-
ated with higher rates of infant mortality [46].
Bozorgmehr et al. (2014) analysed the association of
tuberculosis incidence with four liberalisation indicators:
WTO membership, duration of membership, the trade
and investment components of the KOF index, and the
Freedom House Economic Freedom index, in 22 high-
burden countries, 1990–2010. The authors find WTO
member countries had significantly higher tuberculosis
incidence rates compared with non-members. Results
for the three other indicators were insignificant [47].
Turning to studies of BMI and cardiovascular disease,
Goryakin et al. report a positive association between the
probability of being overweight and a country’s degree of
globalisation. The authors used multi-level longitudinal
models combining country- and individual-level data for
women in 56 low- and middle-income countries, 1992–
2009. The authors report that the association between
BMI and globalisation was stronger for social and political
dimensions of the KOF index compared with the eco-
nomic dimension [48]. De Vogli et al. estimate longitu-
dinal fixed-effects models in a sample of 127 countries,
1980–2008 and also report a positive association between
the economic globalization component of the KOF index
and mean BMI [49]. Finally, the studies of processed food
and beverage consumption by Stuckler et al. (2012) and
Schram et al. (2013) also reported a positive association of
implementing RTAs with rates of cardiovascular disease,
overweight and obesity prevalence [39, 41].
Network co-citation analysis
Included studies were published most frequently in
‘Globalization and Health’ (3 studies) with the remainder
spread across journals public health and social science
(10 studies), book chapters (2 studies) and empirical pol-
icy reports (2 studies) (see Additional file 1). Figure 4
shows the results from our co-citation analysis.
Four clusters are visible in the psychology, social psych-
ology, economics, and public health disciplines. There is a
strong tendency for co-citation of studies in psychology
and social psychology. Co-citations were weaker for public
health and economics and weakest for public health
and psychology.
Methodological quality assessment
Out of the seventeen studies included in our review, fif-
teen analysed repeated cross-sections of country-level
data, one study analysed cross-sectional regional and
firm-level data, and one study analysed repeated cross-
sectional individual level data. Eight studies used bivari-
ate time-series designs, eight used multivariate statistics,
and one analysed a natural experiment. Figure 5 shows
the results from the full quality assessment of included
studies. Overall, six out of seventeen studies were rated
as ‘strong’ on overall methodological quality and risk of
bias; eight studies were rated as ‘moderate’ and three
studies were rated ‘weak’.
Trade and investment measures varied in specificity.
Five studies analysed product-specific changes in RTA
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policies such as the tariff rate, and five studies constructed
dichotomous indicators of participating in RTAs. Three
studies measured general changes to trade or investment
policy, for example mean tariff rates. A further five studies
used an index, four of which used the economic globalisa-
tion component of the KOF index which is a composite
measure of changes to both restrictions and flows of trade
and investment [50].
Discussion
Five main findings can be drawn from our review. First,
implementing RTAs and related policies were associated
with increased consumption of processed food and sugar-
sweetened beverages. Second, granting import licenses for
domestically patented drugs was correlated with increased
access to pharmaceuticals. Third, implementing trade
agreements and associated policies was correlated with
higher cardiovascular disease incidence and higher BMIs,
whilst correlations with under-five mortality, maternal
mortality, tuberculosis, and life expectancy were inconclu-
sive. Fourth, the methodological quality of the studies we
reviewed was predominately ‘weak’ or ‘moderate’ (11 out
of 17 studies). Finally, there was weak co-citation between
studies from public health with economics and psychology.
Our review has a number of limitations. Due to het-
erogeneity in measurement methods, research designs
and outcome variables it was not possible to perform a
meta-analysis or calculate pooled effect sizes. Further,
we restricted our analysis to quantitative studies in order
to evaluate the evidence of causal effects, yet qualitative
studies can also provide useful insights into the mecha-
nisms through which RTAs might affect peoples’ health.
We identified multiple limitations to existing studies.
First, the majority of studies that examined the conse-
quences of RTAs on food, beverage and tobacco con-
sumption and access to pharmaceuticals were descriptive
bivariate analyses. There is possible omitted variable bias,
since trade agreements are often implemented as a conse-
quence of, or alongside, other reforms [51] and macro-
economic changes [52, 53]. Second, studies with stronger
methodological designs tended to analyse the effects of
trade agreements and policies using measures with weak
specificity. The economic globalisation component of
KOF index, used in four studies, can vary as a conse-
quence of changes to both flows and restrictions on trade
and investment [50]. A second approach, constructing a
dichotomous indicator, treats RTAs as a ‘black-box’: it is
unclear which policies within RTAs account for the out-
come in question.
Third, the mechanisms that mediate links between
RTAs and health were seldom explored. Fourth, there
was a strong reliance on country-level data, limiting a
full understanding of the social groups in whom the
health effects of RTAs are concentrated. Fifth, there are
possible health impacts of RTAs via myriad yet unex-
plored pathways that are identified in our conceptual
Fig. 4 Co-citation of studies. Notes: Created using VOSViewer Version 1.6.1. The network map shows co-citation patterns of the 117 journals cited
at least 5 times within the studies we reviewed. Node size corresponds to the number of citations, lines correspond to the existence of a citation
in either direction, and distance between nodes corresponds to the tendency for studies to be cited together by other studies
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framework. This includes benefits and harms to health
due to changes in alcohol consumption, employment se-
curity, regulation, and health-services [13, 14, 54–56].
Sixth, our co-citation analysis identified opportunities
for greater inter-disciplinary collaboration.
Conclusions
These limitations notwithstanding, the systematic review
identifies a common association between implementing
RTAs or related trade and investment policies and higher
consumption of processed foods and sugar-sweetened
beverages, higher prevalence of cardiovascular diseases,
and higher BMIs. Yet, considerable limitations in existing
studies preclude definitive conclusions of causality. There
is an opportunity for researchers to help advance public
health practice and policy making worldwide by address-
ing potential endogeneity, analysing a broader range of
mechanisms and outcomes, and identifying the specific
policies within RTAs that affect people’s health.
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